CTOs on the Move

Embecta

www.embecta.com

 
Embecta will be the name of the independent, publicly-traded company that will hold BD`s Diabetes Care business
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million
  • www.embecta.com
  • 1 Becton Drive
    Franklin Lakes, NJ USA 07417
  • Phone: 201.847.6800

Executives

Name Title Contact Details
Colleen Riley
Senior Vice President and Chief Technology Officer Profile

Similar Companies

Novocol Pharmaceutical

Novocol Pharmaceutical is a Cambridge, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

F H Ayer Manufacturing Company

F H Ayer Manufacturing Company is a Chicago Heights, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Encore Dermatology

Headquartered in Malvern, Pennsylvania, Encore Dermatology is a privately held fully integrated dermatology company with a mission committed to delivering innovative prescription therapies and medical devices to dermatologists focusing on customer service and improving the quality-of-life of patients.

Cansortium

Cansortium Holdings utilizes a unique combination of capital and expertise in making strategic investments to help launch mature and professional cannabis markets. As global regulations evolve, Consortium Holdings is well-positioned to expand its presence in the U.S. and Puerto Rico.

Concert Pharmaceuticals

Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs. The Company`s approach starts with previously studied compounds, including approved drugs, in which deuterium substitution has the potential to enhance clinical safety, tolerability or efficacy. Concert has a broad pipeline of innovative medicines targeting autoimmune and inflammatory diseases and central nervous systems (CNS) disorders.